Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
State health officials announce two-year spending plan prioritizing disproportionately impacted populations, room and board assistance for residential treatment, and naloxone distribution as overdose deaths decline 42.5%.
Federal health officials alert providers to medetomidine, a potent animal sedative spreading through the illegal opioid supply, causing naloxone-resistant overdoses and life-threatening withdrawal.
National Institute on Drug Abuse researchers transform a dangerous synthetic opioid class into a potential therapeutic, creating a compound that relieves pain without causing tolerance, dependence, or fatal overdose risk.
Explore the various addiction treatment options available, from detox and inpatient rehab to outpatient programs and aftercare support.
New clinical criteria establish age-specific guidelines for patients under 18 and transition-aged youth 16-25, emphasizing family involvement and developmentally appropriate care.
New rapid test detects fentanyl at 7 picograms per milliliter, approaching lab-grade sensitivity in a field-deployable strip that could reshape harm reduction and forensic toxicology.
More than 15 clinical trials are testing whether semaglutide and other GLP-1 receptor agonists can reduce cravings by altering dopamine pathways in the brain's reward system.
Preliminary CDC data shows approximately 70,000 Americans died of drug overdoses in 2025, the lowest since before the pandemic, though experts caution the crisis is far from over.
University of Kentucky researchers find that experimental Alzheimer's medication MW150 could reduce brain inflammation and neural damage during alcohol withdrawal, potentially lowering relapse rates.